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Phomopsis bougainvilleicola Prepatellar Bursitis in a Renal Transplant
Recipient
Paloma F. Cariello,a Brian L. Wickes,b Deanna A. Sutton,c Lisa A. Castlebury,d Stuart M. Levitz,a Robert W. Finberg,a
Elizabeth H. Thompson,c Jennifer S. Dalya
Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts, Worcester, Massachusetts, USAa; Department of Microbiology and
Immunologyb and Department of Pathology,c University of Texas Health Science Center, San Antonio, Texas, USA; USDA ARS Systematic Mycology & Microbiology
Laboratory, Beltsville, Maryland, USAd
Prepatellar bursitis is typically a monomicrobial bacterial infection. A fungal cause is rarely identified. We describe a 61-year-old
man who had received a renal transplant 21 months prior to presentation whose synovial fluid and surgical specimens grew
Phomopsis bougainvilleicola, a pycnidial coelomycete.
CASE REPORT
A 61-year-old man with chronic renal disease secondary to di-abetic nephropathy and hypertensive nephrosclerosis under-
went deceased-donor kidney transplantation 21 months prior to
presentation. His posttransplant course was uncomplicated, al-
though he had a history of gout, hepatitis C (genotype 1a), and
coronary artery disease. Although the patient received therapy for
hepatitis C with ribavarin and interferon prior to transplantation,
he did not have a sustained virologic response and his hepatitis C
virus load was 227,754 IU/ml 2 months before transplantation.
The patient developed right knee pain for 2 days and then sought
care. Immunosuppressive agents included tacrolimus, mycophe-
nolate, and prednisone, none of which had been recently changed.
He was a retired carpenter and auto mechanic who was born in
Puerto Rico but had been living in mainland United States since
childhood.
On physical examination, he was in no apparent distress and
was afebrile with marked edema and erythema of the right knee.
He had inability to flex his knee beyond 30 degrees due to excru-
ciating pain. The remainder of the examination was unremark-
able.
Laboratory evaluation showed a complete blood count that
was within normal limits (white blood cell count of 6,100/mm3,
hemoglobin of 14.8 g/dl, hematocrit of 45.1%, and platelet count
of 178,000/mm3), C-reactive protein of 20.1 mg/liter, and an
erythrocyte sedimentation rate of 23 mm/h. Ultrasonography
showed a heterogenous collection in the prepatellar superficial
subcutaneous tissue. Magnetic resonance imaging demonstrated
marked thinning and surface irregularity of the patellar cartilage
with full-thickness cartilage loss at the patellar apex and associated
subchondral bone marrow edema and intact bones (Fig. 1), con-
sistent with prepatellar bursitis. A chest X-ray did not show any
evidence of pulmonary disease.
Arthrocentesis revealed red and cloudy synovial fluid with
232,000 white blood cells, predominantly neutrophils; no crystals
were seen. After arthrocentesis, empirical therapy with vancomycin
and ceftriaxone was initiated to cover the most likely organisms.
However, fluid reaccumulated, requiring repeated arthrocenteses
followed, 5 days later, by surgical drainage in the operating room,
where purulent material under pressure and inflamed synovial
tissue were found.
The same filamentous fungus grew in six different specimens
from the percutaneous aspirates and from the operating room
tissue. Culture from the initial aspirate was planted on thioglyco-
late broth, tryptocase soy agar (TSA) with 5% sheep blood, choc-
olate agar, andMacConkey agar. The routine culture was positive
4 days later and grew on TSA and chocolate agar at 35°C in 5%
CO2. The fungal culture grew on Sabouraud agar at 30°C and also
at 25°C. The mycobiotic slant was negative. Subsequent irrigation
and debridement was performed; tissue from the operating room
had evidence of hyphae seen on a direct calcofluor stain with no
identifiable structures. The fungus could not be identified by rou-
tine laboratory methodology, but it was later identified by DNA
sequencing as Phomopsis bougainvilleicola. In vitro antifungal sus-
ceptibility testingwas performed at ARUPLaboratories using full-
rangeMIC testing and revealed the followingMICs: amphotericin
B, 1 g/ml; anidulafungin, 0.12 g/ml; caspofungin, 0.12 g/ml;
itraconazole, 0.5 g/ml; micafungin, 0.6 g/ml; posaconazole,
0.06 g/ml; and voriconazole, 0.5 g/ml.
The patient was treated with voriconazole for a total of 4
months. Serum concentrations measured by high-performance
liquid chromatography at 1 and 2 months showed peak concen-
trations of 10.7 g/ml and 12.6 g/ml, respectively. Trough con-
centrations showed detectable levels at 6 weeks (4.7 g/ml), at 3
months (4.3 g/ml), and at the end of therapy at 4 months (3.8
g/ml), with a target reference range of 1.0 to 5.5 g/ml. A fol-
low-upX-ray at 3months showed no evidence of osteomyelitis. At
the end of therapy, C-reactive protein normalized to 9.3 mg/liter
(upper normal limit, 10 mg/liter) and the erythrocyte sedimenta-
tion rate remained elevated at 34 mm/h.
Fungal identification. Two synovial fluid isolates were re-
ferred to the Fungus Testing Laboratory (University of Texas
Health Science Center, San Antonio, TX) for identification and
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were added to their culture collection as isolates UTHSC 11-1155
and 11-1180, respectively. Slide cultures were prepared on potato
flake agar, and additional subcultures were made using carnation
leaf agar (CLA) andmedia containing cycloheximide (all prepared
in-house and incubated at 25°C). Isolates failed to grow onmedia
containing cycloheximide after 7 days. Slide cultures remained
sterile, producing only a few chlamydoconidia after 2 weeks.
CLA plates, however, produced triangular, erumpent (bursting
through the surface) pycnidia (asexual fruiting structures) (Fig. 2),
liberating their conidia in a cream-colored “ooze” from the ostiole
(opening) after 3 weeks (Fig. 3A). Conidia were hyaline and of one
type and guttulate (typically containing two small droplets or gut-
tules inside each conidium), measuring 2 by 8 to 10 m. At this
point, the isolate was reported as a pycnidial coelomycete and
sequencing was recommended for further identification. As the
two isolates appeared to be identical, only UTHSC 11-1180 was
sequenced under accession number R-4745. Subsequent subcul-
tures of the isolate revealed short oblong conidia containing 0 to 2
oil-like droplets, termed alpha conidia, as well as long, filiform,
curved conidia, known as beta conidia, measuring approximately
0.5 to 1 by 20 to 25m (Fig. 3B). UTHSC isolate number 11-1180
(R-4745) has been deposited in the University of Alberta Micro-
fungus Collection under accession number UAMH 11634.
DNA sequencing. Template DNA from isolate R-4745 was re-
covered as described previously (1) using Prepman Ultra reagent
(Applied Biosystems, Foster City, CA) to lyse cells. TemplateDNA
was amplified and sequenced using the internal transcribed spacer
1 (ITS1), ITS4, NL1, and NL4 primers to yield the ITS sequences
and D1 and D2 sequences as described previously (1). The EF1-
gene sequence was obtained by PCR and sequenced as described
previously (2). Sequencing was performed at the UTHSCSA Ad-
vanced Nucleic Acids Core Facility and used to search the
GenBank database at http://www.ncbi.nih.gov using the BLASTn
search algorithm. Sequence-based identities with a cutoff of 97%
or greater and query coverage of 90% were considered signifi-
cant. The best hit was defined as the sequence with the highest
maximum identity to the query sequence.
Molecular identification. ITS sequences for representative
species of Phomopsis (sexual state Diaporthe) were obtained
from GenBank and aligned using MAFFT (http://mafft.cbrc.jp
/alignment/software/). Maximum likelihood phylogenetic analy-
sis of the ITS regions using PhyML (3) placed isolate 11-1180 in a
clade containing Phomopsis bougainvilleicola, a relatively recently
described species from China, with 100% bootstrap support. Ad-
ditional isolates in the clade have been collected from various
plant hosts from the United States, Puerto Rico, and Jamaica
(Fig. 4). Phomopsis averrhoae is also included in this clade; how-
ever, as it is a later name, we consider P. bougainvilleicola to be the
correct name for this clade. Analysis of the EF1- gene region
using NCBI BLAST found a 97% match over 98% coverage with
an unidentified Phomopsis isolate from mangrove in China
(EU259179), with P. phoenicicola (GQ250349) as the next closest
match.
In most patients, including transplant recipients, septic arthri-
tis and bursitis are typically caused by monomicrobial bacterial
infections. A fungal cause is rarely identified. Cases of fungal in-
fection in the literature have been reported after penetration of
FIG 1 (A) Magnetic resonance imaging (axial view): 5.6-by-4.2-by-1.3-cm anterior loculated fluid collection and diffuse edema. (B) Ultrasonography: 5.8-by-
2.1-cm heterogeneous collection in prepatellar area.
FIG 2 (A) Pycnidia on carnation leaf agar after 3 weeks of incubation at 25°C in ambient air; (B) closeup of triangular, erumpent pycnidia on carnation leaf agar.
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soft tissue injuries with organic matter, but these are rare. Our
patient’s case illustrates the need to pursue both laboratory iden-
tification and antifungal susceptibility testing to provide the best
therapy for patients with invasive fungal infection.
Coelomycetes are fungi that produce their conidia within sev-
eral different types of asexual fruiting structures referred to as
conidioma, one of which is a pycnidium, as opposed to the more
common fungi known as hyphomycetes, such as Aspergillus spe-
cies, for example, which bear their conidia free to the air. They are
inhabitants of branches and leaves of numerous host plants. Al-
though highly prevalent in nature, they rarely cause human dis-
ease. The coelomycete genus Phomopsis contains melanized or
dematiaceous fungus. Identification rarely goes beyond the genus
level, and they are recognized by their black, pycnidial conidi-
omata (globose to subglobose structures lined with conidio-
genous cells) that produce hyaline to pale brown mycelium with
basic types of conidia: alpha (short and ellipsoidal) and beta (long,
filamentous, curved) (4, 5). There are rare reports of Phomopsis
species identified as human pathogens in the literature. To our
knowledge, this is the first reported case of human disease in
which Phomopsis bougainvilleicola was identified. Initially identi-
fied only as a melanized pycnidial coelomycete, subsequent pro-
duction of alpha and beta conidia, the hallmark of the genus,
confirmed the presence of a Phomopsis sp. Definitive identifica-
tion to the species level required DNA sequencing and compari-
son with the voucher strain.
Opportunistic mycoses are commonly caused by filamentous
fungi such as Aspergillus spp. and Fusarium spp. bearing their
conidia free. Coelomycete human disease is rarely reported; how-
FIG 3 (A) Conidia being liberated in an “ooze” from an ostiole (opening) in
the pycnidium; (B) short oblong alpha conidia containing 0 to 2 oil droplets
and long, filiform, curved beta conidia.
FIG 4 Phylogenetic tree showing comparison with voucher strain.
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ever, several genera have been recovered from clinical specimens
(6). Infection is thought to be acquired by accidental inoculation
of the fungus into subcutaneous tissue by pricking with thorns or
spines of different plants, and it is more frequently described in
peopleworking in forest or rural areas. The infectionmayprogress
indolently for years or even decades.
The only 3 cases of Phomopsis causing human disease reported
in the literature were a renal-transplant recipient patient with
Phomopsis longicolla in a nodular lesion of the distal phalange (7),
a Phomopsis sp. causing osteomyelitis in another immunosup-
pressed patient on prednisone and methotrexate for rheumatoid
arthritis (5), and a case of fungal scleral keratitis caused by
Phomopsis phoenicicola in a patient after pterygium surgery (re-
moval of conjunctival tissue that has grown over the edge of the
cornea) (8).
Our patient, however, did not report any direct trauma to the
affected area, although he could have had remote inoculation of
which he was unaware. In the other cases reported in immuno-
suppressed patients, therewas a remarkable traumatic penetrating
injury prior to transplantation, suggesting that a significant
amount of organic matter was introduced and persisted in a
subclinical or latent form (9). This implies that skin disruption
and immunosuppression do not necessarily have to occur simul-
taneously and that subsequent immunosuppression may trigger
an active infection.
As in other rare cases of invasive fungal disease in immuno-
compromised hosts, there was a prolonged period (21months) of
immunosuppression before development of disease.We were un-
able to identify a potential source or pinpoint the time of initial
inoculation. Although the setting of his presentation was acute, it
is plausible that he had acquired the infection years before and that
immunosuppression after renal transplantation had allowed fun-
gal growth. Dematiaceous mold infections are rare; however, they
are increasing in the immunosuppressed host and must be con-
sidered in the differential diagnosis when a typical etiologic agent
is not identified.
All reported cases of Phomopsis human disease were treated
with surgical debridement (5, 7, 9) in addition to antifungal ther-
apy. Recommendations for empirical therapy are difficult tomake
given the limited number of described cases, the paucity of in vitro
susceptibility data, and the lack of guidelines for interpretation
available from the Clinical and Laboratory Standards Institute
(CLSI). Nevertheless, we advise performing susceptibility testing
on patient isolates and obtaining drug levels with the goal ofmain-
taining serum concentrations above the MIC. Other factors re-
quiring consideration when administering antifungal drugs to
transplant recipients include the necessity of achieving appropri-
ate tissue penetration and drug-drug interactions. For example,
azole antifungal drugs inhibit the metabolism of tacrolimus, an
antirejection drug widely used in transplant recipients (10, 11).
Painful periostitis with fluoride excess has also been described in
posttransplant patients with long-term voriconazole use (12), and
close management of the patient’s clinical status and medication
level is critical.
Organ transplantation has been performed with an increasing
frequency worldwide, increasing the number of patients on im-
munosuppressive therapy. This has given rise to unusual clinical
forms of superficial and invasive fungal infections. Practitioners
should be aware and mindful of the possibility of these fungal
infections when evaluating such patients. Our patient showed a
good response with a combination of antifungal and surgical ther-
apy, and no recurrence was noted for at least 15 months after the
discontinuation of antifungal therapy.
Nucleotide sequence accession numbers. Sequences deter-
mined in this work were deposited in GenBank under accession
numbers JX847139, JX847137, and JX847138 for ITS, D1 and D2,
and EF1-, respectively.
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